Imaging of Hepatobiliary Cancer.

Autor: Carney BW; Department of Radiology, University of California, Davis Health System, Sacramento, California. Electronic address: bcarney@ucdavis.edu., Larson MC; Department of Radiology, University of California, Davis Health System, Sacramento, California., Corwin MT; Department of Radiology, University of California, Davis Health System, Sacramento, California., Lamba R; Department of Radiology, University of California, Davis Health System, Sacramento, California.
Jazyk: angličtina
Zdroj: Current problems in cancer [Curr Probl Cancer] 2023 Apr; Vol. 47 (2), pp. 100964. Date of Electronic Publication: 2023 Jun 04.
DOI: 10.1016/j.currproblcancer.2023.100964
Abstrakt: The liver and biliary tree are common sites of primary and secondary malignancies. MRI followed by CT is the mainstay for the imaging characterization of these malignancies with the dynamically acquired contrast enhanced phases being the most important for diagnosis. The liver imaging reporting and data system classification provides a useful framework for reporting lesions in patents with underlying cirrhosis or who are at high risk for developing hepatocellular carcinoma. Detection of metastases is improved with the use of liver specific MRI contrast agents and diffusion weighted sequences. Aside from hepatocellular carcinoma, which is often diagnosed noninvasively, other primary hepatobiliary tumors may require biopsy for definite diagnosis, especially when presenting with nonclassic imaging findings. In this review, we examine the imaging findings of common and less common hepatobiliary tumors.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023. Published by Elsevier Inc.)
Databáze: MEDLINE
Externí odkaz: